As our aim was to indicate general tissue specific carcinogenic properties, we used all the known subtypes of these cancers, including (1)
hyper mutated and non-hypermutated colon cancers; (2) lung adenocarcinomas, large cell carcinomas, and squamous cell carcinomas (3) HER2 positive, basal,
luminal A and
luminal B breast cancers; and (4) hepatitis B or hepatitis C, cirrhosis or other agent causing hepatocellular carcinoma data.